THY1 and Parkinson disease: The loss of striatal terminals is suggested to precede dopaminergic cell loss in PD [61]; therefore, striatal degeneration in Thy1-aSyn mice together with the behavioral readouts provides a platform to test drugs which modify the underlying pathogenic processes.